20 articles
New research reveals intelectin-2 protein strengthens gut mucus while directly neutralizing harmful bacteria, including antibiotic-resistant strains.
New mouse research reveals how intestinal aging creates a feedback loop of inflammation, barrier breakdown, and microbiome decline.
A newly discovered bacteriophage inside common gut bacteria appears strongly linked to colorectal cancer, potentially explaining a long-standing medical paradox.
A Phase 1b trial shows a daily probiotic capsule may restore immunotherapy response in advanced melanoma patients who had stopped responding.
A gut microbe converts a common pollutant into an inflammation trigger linked to depression, revealing a new molecular pathway.
Scientists discover harmful bacterial sugars in the gut trigger immune attacks that damage the brain in ALS and dementia patients.
Common respiratory bacterium persists in retinas and brains, triggering inflammation and amyloid buildup linked to cognitive decline.
A Lactobacillus strain found in centenarians reduced lung fibrosis scores by 30% and collagen by 40% in aging mice via the gut-lung axis.
A Nature Medicine study reveals how microglial state shifts drive Alzheimer's, pointing to a promising oral drug now in Phase 1 trials.
Johns Hopkins study reveals how oral bacteria can travel to breast tissue, causing DNA damage and accelerating tumor growth.
Mouse study reveals the FXR bile acid receptor links gut microbes to arterial plaque in sleep apnea, hinting at new preventive targets.
Scientists discover friendly gut bacteria use injection systems to send proteins into human cells, influencing immunity and inflammation.
New research proposes the immune system actively controls gut microbiome diversity, and that aging-related immune decline drives dysbiosis.
A molecule called OLE restores microglia's protective function, reducing amyloid plaques and improving memory in animal models.
New research reveals that close social contact, not just shared environment, actively transfers gut microbes between household members.
New research explores whether transplanting gut bacteria from vegans can reduce TMAO, a compound linked to heart disease, cancer, and diabetes.
New research identifies a microglial 'tipping point' that could explain why some people resist Alzheimer's despite having the same brain plaques.
Non-obese MASLD patients face 3x higher Alzheimer's mortality risk, plus Vitamin E shows liver benefits in new gastroenterology roundup.
An oral iron-targeting drug significantly slowed Multiple System Atrophy progression in a Phase 2 trial, with Phase 3 planning underway.
MIT researchers discover cysteine activates immune cells that boost intestinal stem cells, opening doors to nutrition-based gut therapies.
